RAMP TROPONIN I Test

The definitive biomarker for acute myocardial infarction (AMI)

WHEN EARLY RECOGNITION OF AMI IS KEY

Estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths
There are 32.4 million myocardial infarctions and strokes worldwide every year
The sensitivity of ECGs for MI is poor (28%-54%)
One-thirds of MI patients do not present with chest pain but instead with non-specific symptoms such as fatigue, nausea, dizziness

Quantitative fluorescent immunoassay

Sample: 75 µL EDTA whole blood

Time to Result: ~19 minutes

Single use test cartridge with barcode defines lot specific calibration

Proprietary RAMP® buffer enhances performance

A calibrated transfer device is provided with every kit

RAMP ratio corrects for sources of analytical variability A calibrated transfer device is provided with every kit

Cardiac Troponin is the gold standard test for myocardial infarction and is usually the first test ordered for patients with chest pain
Measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI)
With RAMP Troponin I, healthcare professionals can obtain a quantitative measurement of cardiac troponin I from 75uL of blood without the need for centrifugation
RAMP tests are individual, single-use quantitative tests that provide rapid, accurate, lab quality results within minutes

24 Hour Technical Support Available for all RAMP Customers

Start Testing Today